BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

New Series of Innovative Hydroxyapatite Biomaterials Developed at CERAM


12/9/2011 10:28:22 AM

9 December 2011 – Stoke-on-Trent, UK - Ceram, the materials technology consultancy, is pleased to announce that it has developed a new range of Hydroxyapatite (HA) biomaterials. By substituting different elements into HA to change its basic chemical whilst retaining its valuable physical structure, Ceram has been able to produce a range of biomaterials, multi-elements-substituted Hydroxyapatites (mx-HA), with different biological properties to extend the medical applications that HA can be used for and other potential applications not explored yet.

Although Hydroxyapatite has been widely used in the medical sector, it has had limited applications because of its fixed chemistry. Ceram’s innovative technology has allowed different species, such as zinc and sulphate, to be substituted in conjunction into the HA crystal. The possibilities for this technology are endless; from the development of coatings which are both antimicrobial and osteo-promotive to bone cements that can have both a heightened bioactivity and modified structural characteristics (be that toughness, solubility, porosity or surface charge)

Ceram has filed for IP and is currently looking for biologics, medical devices and dental manufacturers to work with to develop bespoke HA based materials for bespoke applications. Ceram would also welcome additional collaboration with research institutes and academia to explore the new series of HA-based materials to find new applications.



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES